bromocriptine mesylate
Generic: bromocriptine mesylate
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
bromocriptine mesylate
Generic Name
bromocriptine mesylate
Labeler
mylan pharmaceuticals inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
bromocriptine mesylate 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0378-7096
Product ID
0378-7096_caaa8c54-ee5c-47a9-8455-1f49fab45143
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077226
Listing Expiration
2026-12-31
Marketing Start
2013-06-17
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03787096
Hyphenated Format
0378-7096
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bromocriptine mesylate (source: ndc)
Generic Name
bromocriptine mesylate (source: ndc)
Application Number
ANDA077226 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE, UNIT-DOSE (0378-7096-01)
- 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0378-7096-93)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "caaa8c54-ee5c-47a9-8455-1f49fab45143", "openfda": {"unii": ["FFP983J3OD"], "rxcui": ["197412"], "spl_set_id": ["72d8eefe-c066-41b6-8922-9586f1cf47a1"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, UNIT-DOSE (0378-7096-01)", "package_ndc": "0378-7096-01", "marketing_start_date": "20130701"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0378-7096-93)", "package_ndc": "0378-7096-93", "marketing_start_date": "20130617"}], "brand_name": "Bromocriptine Mesylate", "product_id": "0378-7096_caaa8c54-ee5c-47a9-8455-1f49fab45143", "dosage_form": "CAPSULE", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "0378-7096", "generic_name": "bromocriptine mesylate", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bromocriptine Mesylate", "active_ingredients": [{"name": "BROMOCRIPTINE MESYLATE", "strength": "5 mg/1"}], "application_number": "ANDA077226", "marketing_category": "ANDA", "marketing_start_date": "20130617", "listing_expiration_date": "20261231"}